Lu, Y. et al. reported that the ETS1/miR-23a-3p/ACSL4 axis contributes to sorafenib resistance in hepatocellular carcinoma (HCC) through regulating ferroptosis. Here, ACSL4 is linked to hepatocellular carcinoma.